PNT
Asset Logo

Panther Metals Ltd

πŸ‡¦πŸ‡Ί ASX

⛏️ MINING

Compare
Add to watchlist
πŸ‘‘ Overview

πŸ“ˆ Performance

πŸ’΅ Cost

πŸ€“ Advanced

πŸ‘¨β€πŸ‘©β€πŸ‘§β€πŸ‘¦ Community

πŸ“ˆ

-30.44%
Annual Growth

3 years average annual growth

πŸ’΅

$ 500
Minimum Order

Due to regulatory requirements

🌏

1
Pearlers Invested

Since January 2020

πŸ‘‘ Overview

Key information
πŸ”Ž Fund Overview

Panther Metals Ltd. focuses on identifying and acquiring prospective mineral exploration projects. The company is headquartered in Perth, Western Australia. The company went IPO on 2021-12-10. The firm is a nickel-cobalt and gold explorer with drill-ready targets across six projects in the mining districts of Laverton, Western Australia, and three Projects in the Northern Territory. The company is focused on the exploration and development of battery and precious metals. Its projects include battery metals projects and precious metals project. Its battery metals project includes Coglia project and Red Flag project. The Precious Metals project include Annaburroo project, Marrakai project, Burtville East prospect, Ironstone prospect, 40-mile camp prospect, comet well prospect, and Mikado project. The Coglia Nickel-Cobalt Project located around 70 kilometers (km) southeast of Laverton. The Red Flag is located in a prolific nickel-cobalt belt, 25 km west of Laverton. The 149.8 square kilometers (2km) Annaburro Project is located approximately 100 km southeast of Darwin within the Pine Creek Orogen.

πŸ“ˆ Performance

Price History

-89.94%

1M

1Y

All Time

Graph

Table

Unsure how much or often to invest?
πŸ—“οΈ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out β†’
πŸ’΅ Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out β†’
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out β†’

πŸ’΅ Costs

πŸ’΅

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

πŸ’Ό

N/A
Management Fee

Included in unit price, not charged by Pearler

πŸ’Έ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πŸ’Έ Net fee calculator

πŸ€“ Advanced information

Technical Info

πŸ’° Price*

$0.02

*Price may be up to 24 hours old

πŸ‘©β€πŸ‘©β€πŸ‘¦ Community Insights

How our community is investing

🌏 Pearlers invested in PNT

1

πŸ“Š Total Capital Earnings

N/A

πŸ”ƒ Average investment frequency

10 weeks

πŸ’΅ Average investment amount

$5,294

⏰ Last time a customer invested in PNT

32 days
PNT investor breakdown
πŸ’΅ Income of investors

More than 200k

150k - 200k

100k - 150k

100%

50k - 100k

Less than 50k

πŸ‘Ά Age of investors

18 - 25

26 - 34

35 - 90

100%
πŸ™‹ Legal gender of investors

Female

Male

100%

Pearlers who invest in PNT also invest in...

Gold

PMGOLD

PMGOLD.AX was created on 2003-05-09 by Perth Mint. The fund's investment portfolio concentrates primarily on gold commodities. PMGOLD.AX is designed to track the international price of gold in Australian dollars and offers investors a simple, low cost way to access the returns on gold.

πŸ™Œ Performance (5Yr p.a)

18.22%

πŸ“Š Share price

$41.20 AUD

πŸ“ˆ HIGH PRICE GROWTH

Find Out More

ETPMAG.AX was created on 2009-01-02 by Global X. The fund's investment portfolio concentrates primarily on silver commodities. ETFS Physical Silver (ETPMAG.AX) is designed to offer investors a simple, costefficient and secure way to access physical silver by providing a return equivalent to the movements in the silver spot price less the applicable management fee.

πŸ™Œ Performance (5Yr p.a)

17.21%

πŸ“Š Share price

$44.02 AUD

πŸ“ˆ HIGH PRICE GROWTH

Imugene Ltd. is a biopharmaceutical company, which engages in the research, development, and commercialisation of health technologies against cancer. The company is headquartered in Sydney, New South Wales. The company is engaged in developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Its platform technology seeks to harness and promote the body’s immune system against cancerous tumors. Its product pipeline includes an off-the-shelf (allogeneic) cell therapy CAR T drug Azer-Cel (azercabtagene zapreleucel) which targets CD19 to attack blood cancer. Its pipeline includes an Oncolytic Virus and B-Cell Immunotherapies aimed at treating a variety of cancers in combination with standard of care drugs and immunotherapies. Its lead candidate is a chimeric vaccinia (pox) virus known as CF33, which is a combination of genomic sequences from multiple vaccinia virus strains to generate a new, safer and more potent virus. Its Chimeric antigen receptor (CAR)-engineered T cells (CAR T) are T cells redirected against tumors through engineered expression of CARs.

πŸ™Œ Performance (5Yr p.a)

-5.00%

πŸ“Š Share price

$0.04 AUD

🧬 BIOTECHNOLOGY

Novatti Group Ltd. provides software technology and systems integration services. The company is headquartered in Melbourne, Victoria. The company went IPO on 2016-01-18. The Company’s segments include Technology, Business automation, Acquiring, Alternative payments, Banking services, Issuing, and ATX payments. Technology segment develops, deploys, and supports specialized mobile and alternate payment technology, primarily through the deployment of the Novatti Wallet Platform. Business automation segment automates business processes, including customer engagement, subscription management and embedded payments. Acquiring segment accepts a range of payments. Alternative payments segment includes bill payments for international and local university and college students. Banking services segment offers customers an alternative payment method in the form of a prepaid cash voucher. Issuing segment provides a payment system centered around digital and physical prepaid, gift and debit cards for a variety of fintechs and commercial enterprises. ATX payments segment provides a payments network across Malaysia.

πŸ™Œ Performance (5Yr p.a)

-17.02%

πŸ“Š Share price

$0.03 AUD

πŸ€– TECHNOLOGY

GDX.AX was created on 2015-06-26 by VanEck. The fund's investment portfolio concentrates primarily on materials equity. To achieve this investment objective, GDX.AX employs a passive management strategy of investing in the NYSE-listed GDX.AX issued and operated by VanEck in the United States.

πŸ™Œ Performance (5Yr p.a)

10.37%

πŸ“Š Share price

$59.90 AUD

πŸ•ŠοΈ SOCIALLY AWARE

🧱 MATERIALS

πŸ“ˆ HIGH PRICE GROWTH

Want more shares? Try these...

πŸ“Š Share price

$0.00 AUD

Polynovo Ltd. engages in the development of medical devices, utilizing the patented polymer technology NovoSorb. The company is headquartered in Melbourne, Victoria and currently employs 237 full-time employees. Its solutions include NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb MTX. NovoSorb BTM is a synthetic, biodegradable and biocompatible device designed to facilitate the dermis to grow within a patented polyurethane matrix when lost through extensive surgery, trauma or burn. NovoSorb BTM is indicated for use in the management of wounds, including partial and full thickness wounds, pressure ulcers, venous and diabetic ulcers, chronic and vascular ulcers, surgical wounds, trauma wounds and draining wounds. Its development program covers breast sling, hernia, and orthopedic applications. NovoSorb MTX is available in a range of sizes to address acute and chronic dermal wounds and is comprised of a 2mm biodegradable foam with no sealing membrane.

πŸ™Œ Performance (5Yr p.a)

2.00%

πŸ“Š Share price

$1.98 AUD

🩺 HEALTH CARE

πŸ“Š Share price

$0.02 AUD

Pantoro Ltd. engages in the exploration and processing of gold mining. The company is headquartered in Perth, Western Australia. The Halls Creek Project owns the only commercial scale gold processing facility in the Kimberley Region of Western Australia, with the closest plant approximately 300 kilometers (km) to the south. Its Norseman Gold Project is located in the Eastern Goldfields of Western Australia, at the southern end of the Norseman-Wiluna greenstone belt. The project lies approximately 725 km east of Perth, 200 km south of Kalgoorlie, and 200 km north of Esperance. The project comprises various near-contiguous mining tenements, and its tenure includes approximately 70 lineal km of the prospective Norseman-Wiluna greenstone belt covering approximately 800 square kilometers. The firm has a portfolio of regional exploration targets located near the Nicolsons Project, approximately 45 km southwest of Halls Creek in Western Australia.

πŸ™Œ Performance (5Yr p.a)

-6.21%

πŸ“Š Share price

$0.10 AUD

⛏️ MINING

Compare
Add to watchlist